(2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide
C39H47N9O5S — CID 162711843
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide
(2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide (PubChem CID 162711843) has the molecular formula C39H47N9O5S and a molecular weight of 753.93 g/mol. Its IUPAC name is (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide.
Molecular Properties
| Compound Name | (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 162711843 |
| Molecular Formula | C39H47N9O5S |
| Molecular Weight | 753.93 g/mol |
| Exact Mass | 753.34 |
| IUPAC Name | (2S,4R)-4-hydroxy-1-[(2S)-2-[[2-[4-(2-hydroxyphenyl)-1,5,6,8,12-pentazatricyclo[8.4.0.02,7]tetradeca-2,4,6-trien-12-yl]acetyl]amino]-3,3-dimethylbutanoyl]-N-[[4-(5-methyl-1,3-thiazol-4-yl)phenyl]methyl]pyrrolidine-2-carboxamide |
| SMILES | Cc1scnc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CN2CCN3c4cc(-c5ccccc5O)nnc4NCC3C2)C(C)(C)C)cc1 |
| InChI | InChI=1S/C39H47N9O5S/c1-23-34(42-22-54-23)25-11-9-24(10-12-25)17-41-37(52)31-15-27(49)20-48(31)38(53)35(39(2,3)4)43-33(51)21-46-13-14-47-26(19-46)18-40-36-30(47)16-29(44-45-36)28-7-5-6-8-32(28)50/h5-12,16,22,26-27,31,35,49-50H,13-15,17-21H2,1-4H3,(H,40,45)(H,41,52)(H,43,51)/t26?,27-,31+,35-/m1/s1 |
| InChIKey | HCMYOXQNMXWNNB-HRNRDZRMSA-N |
| XLogP | 3.01 |
| TPSA | 176.15 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 54 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 753.93 |
| LogP ≤ 5 | 3.01 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 12 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162711843 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.